An Act expanding access to perimenopause and menopause care
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill establishes a special legislative commission to study and improve access to perimenopause and menopause care in Massachusetts. The commission will gather data, assess current services, identify gaps in care, and recommend changes to healthcare education, coverage, and workplace policies. It also mandates the Department of Public Health to disseminate information about these conditions and requires healthcare providers to receive continuing education on their diagnosis and treatment.
Key provisions
- Creates a special legislative commission to study perimenopause and menopause care.
- Requires the commission to collect data on prevalence and access to care, disaggregated by demographic factors.
- Directs the Department of Public Health to provide public information about perimenopause and menopause.
- Mandates continuing education for healthcare providers on perimenopause and menopause diagnosis and treatment.
- Requires insurance coverage for hormonal and non-hormonal therapies for perimenopause and menopause.
- Establishes ‘Perimenopause Awareness Month’ and ‘Menopause Awareness Month’.
- Addresses workplace policies related to perimenopause and menopause.
- Requires employers to provide reasonable accommodations for employees experiencing perimenopause or menopause.
Who is affected
- Individuals experiencing perimenopause and menopause
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
11 on record
Primary sponsor
Joint Committee on Public Health
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours